Surrogacy Market Trends: Rising Infertility Rates, Legal Frameworks & Forecast to 2034

According to IMARC Group's latest research publication, global surrogacy market size reached USD 204.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 329.2 Million by 2034, exhibiting steady expansion driven by rising infertility rates, growing societal acceptance, and advancements in assisted reproductive technologies.

How Technology and Policy are Reshaping the Future of Surrogacy Market

• Legal Framework Advancements and Regulatory Clarity: Jurisdictions with clear and supportive surrogacy legislation are emerging as preferred destinations for intended parents globally. Countries and states with transparent legal frameworks eliminate unnecessary risks, define parental custody rights, and protect all parties involved in the arrangement. For instance, gestational surrogacy accounts for approximately 90% of all surrogacy arrangements worldwide, with legal certainty being a primary reason intended parents select specific geographies for their surrogacy journey. This regulatory clarity is attracting both domestic and international clients, widening market reach and unlocking new demand pools previously deterred by legal ambiguity.
• Advancements in IVF and Embryo Transfer Technologies: Innovations in assisted reproductive technology are fundamentally transforming the surrogacy landscape by improving success rates and reducing cycle failures. The pregnancy success rate per embryo transfer in gestational surrogacy currently ranges from 30% to 60%, with higher outcomes observed when using younger, healthier surrogates. Pre-implantation Genetic Testing (PGT)-screened embryos achieve live birth rates of 75 to 80%, making genetic testing an increasingly standard component of the surrogacy process. These clinical improvements are directly increasing confidence among intended parents and driving repeat engagement with fertility clinics and surrogacy agencies.
• Rising LGBTQ+ Inclusion and Non-Traditional Family Formation: The global recognition of LGBTQ+ rights is creating a new and rapidly expanding demographic of intended parents. Same-sex couples, for whom surrogacy represents one of very few biological pathways to parenthood, are increasingly turning to fertility clinics and surrogacy agencies in jurisdictions where their rights are legally protected. Surrogacy agencies are actively responding by launching inclusive campaigns and dedicated programs. Circle Surrogacy sponsored the "A Lifetime of Pride and Joy" campaign, celebrating family equality and raising awareness around accessible fertility care for the LGBTQ+ population, reflecting how market leaders are aligning commercial strategy with social progress.
• Digital Integration and AI-Powered Fertility Care: Leading surrogacy and fertility clinic networks are investing in digital tools to optimize clinical outcomes and improve the patient journey. AI-driven embryo assessment tools are being integrated across fertility clinic networks to enhance IVF success prediction and reduce failed transfer cycles. Digital platforms are also streamlining the coordination between intended parents, surrogates, medical professionals, and legal advisors, reducing friction and shortening timelines. These innovations are particularly significant in markets with large geographic spreads, where remote monitoring and digital case management are enabling clinics to serve clients across wider regions more efficiently.
• Fertility Tourism and Cross-Border Surrogacy Growth: Differences in legal frameworks, cost structures, and medical infrastructure across countries are driving significant cross-border surrogacy activity. Intended parents from regions with restrictive or unclear surrogacy laws, particularly parts of Europe and Asia, are increasingly traveling to North America, specifically the United States, to access surrogacy services under established legal protections. The multi-ethnic surrogate populations in North America, combined with high medical standards and enforceable contracts, make the region the preferred global hub. This fertility tourism dynamic is expanding the addressable market well beyond domestic demand, adding an international revenue dimension to established clinic networks and agencies.

Surrogacy Industry Overview:

The global surrogacy market is experiencing strong growth momentum, underpinned by a convergence of medical, legal, and social forces that are expanding access to surrogacy and normalizing it as a family-building pathway. North America continues to lead the global market, benefiting from well-established legal frameworks in states such as California, Nevada, and Washington in the United States, where pre-birth orders, enforceable surrogacy contracts, and clear parental rights protections create a secure environment for all parties. Canada's Assisted Human Reproduction Act similarly permits altruistic surrogacy with strong safeguards, reinforcing the region's dominance. Fertility clinics are the primary service providers in the market, offering end-to-end management of surrogacy arrangements from initial medical assessment and IVF procedures through to embryo monitoring and legal coordination. The IVF with Intracytoplasmic Sperm Injection (ICSI) technique holds the largest technology segment share, as it directly addresses male infertility barriers by injecting a single sperm into an egg, expanding surrogacy eligibility to a broader range of intended parents. Gestational surrogacy dominates the market by type, given its legal, genetic, and psychological advantages over traditional surrogacy. Key market players are differentiating through genetic testing partnerships, digital platform integration, and sustainability-focused clinical approaches, marking a significant evolution in how surrogacy services are being delivered and marketed globally. India's regulatory shift through the Surrogacy Regulation Act, which restricts commercial surrogacy to altruistic arrangements for eligible citizens, has formalized the domestic segment and pushed fertility networks toward greater compliance and accountability, with major networks such as Nova IVF Fertility accelerating clinic expansion into Tier 2 cities to meet growing demand.

Request a Sample Report with the Latest Data and Forecasts

Surrogacy Market Trends and Drivers

The most significant structural driver of the surrogacy market is the rising global prevalence of infertility. Medical literature and public health data consistently highlight infertility as a growing concern across both developed and developing nations, driven by delayed family planning, lifestyle factors, and increasing rates of conditions such as polycystic ovary syndrome and endometriosis. This expanding base of individuals and couples unable to conceive naturally generates consistent and compounding demand for assisted reproductive technologies, with surrogacy serving as the pathway of last resort and, increasingly, a first-choice option for those unable to carry a pregnancy. The growing awareness of surrogacy as a medically sound and legally viable option is further accelerating uptake. Studies in emerging markets such as Lebanon have found that 54.8% of medical students and 52.9% of lawyers surveyed expressed support for surrogacy, illustrating how professional acceptance is broadening even in culturally conservative regions. This shift in expert opinion is critical because it directly influences public discourse, patient counseling, and policy formation, creating a virtuous cycle of awareness and adoption.

Technological progress in assisted reproduction is acting as both a driver and a differentiator in the surrogacy market. The dominance of IVF with ICSI as the preferred clinical technology reflects how far reproductive medicine has advanced in addressing the full spectrum of fertility challenges. Genetic screening advancements, particularly PGT, allow embryos to be evaluated for chromosomal abnormalities before transfer, significantly improving the probability of a successful pregnancy and a healthy child. Approximately 2% of all babies born in the United States are now conceived using assisted reproductive technology, a figure that underscores how mainstream these clinical pathways have become. For the surrogacy market specifically, higher IVF success rates translate directly into greater willingness among intended parents to proceed with surrogacy arrangements, as the medical risk profile has become more predictable and manageable. Fertility clinics and surrogacy agencies that invest in cutting-edge technology and transparent outcome reporting are gaining competitive advantage, attracting both domestic clients and the rapidly growing international fertility tourism segment.

Regulatory evolution and shifting social norms are collectively expanding the viable market for surrogacy across multiple geographies simultaneously. The increasing recognition of LGBTQ+ rights in legislation across North America, Western Europe, and parts of Asia-Pacific is directly translating into new demand from same-sex couples seeking biological parenthood through surrogacy. At the same time, governments are being compelled to create clearer legal frameworks as demand grows, with several jurisdictions that previously had no specific surrogacy legislation now introducing comprehensive regulatory structures. This policy momentum reduces legal uncertainty, making surrogacy a more accessible and trustworthy option for a wider population. Economic considerations also play a role, with the availability of surrogacy services at varying cost points across different countries enabling intended parents from diverse income brackets to find viable options. The proliferation of digital platforms connecting intended parents with surrogacy agencies, legal experts, and medical professionals is reducing information asymmetry and lowering the barriers to initiating the surrogacy journey, further accelerating market growth.

Leading Companies Operating in the Global Surrogacy Industry:

• Bourn Hall Fertility Clinic
• Care Fertility
• Circle Surrogacy
• Extraordinary Conceptions
• Growing Generations
• Houston Fertility Center
• IVIRMA Global
• Kindbody
• Max Healthcare
• New Hope Fertility Clinic
• Nova IVF
• Ovation Fertility

Surrogacy Market Report Segmentation:

By Type:

• Gestational Surrogacy
• Traditional Surrogacy

Gestational surrogacy represents the largest segment, as it eliminates the genetic connection between the surrogate and the child, addressing key legal and psychological challenges while benefiting from higher IVF success rates.

By Technology:

• IVF with ICSI
• IVF without ICSI
• Intrauterine Insemination

IVF with ICSI holds the largest technology share owing to its ability to overcome male infertility challenges and its strong clinical success outcomes, making it the preferred protocol across leading surrogacy programs globally.

By Service Provider:

• Hospitals
• Fertility Clinics
• Others

Fertility clinics account for the largest service provider share due to their specialized medical expertise, full-service surrogacy coordination capabilities, and close integration with legal and agency partners across the surrogacy ecosystem.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America exhibits a clear dominance in the surrogacy market due to its comprehensive legal frameworks, advanced fertility clinic infrastructure, high societal acceptance of diverse family structures, and its position as the preferred destination for international intended parents seeking enforceable surrogacy agreements.

Recent News and Developments in Surrogacy Market

• March 2025: Kindbody announced the integration of AI-driven embryo assessment tools across its fertility clinic network, aimed at improving IVF success prediction and reducing failed embryo transfer cycles within surrogacy programs, enhancing clinical outcomes for intended parents.
• January 2025: Growing Generations expanded its international surrogacy coordination services to accommodate rising demand from European and Asian intended parents seeking gestational surrogacy arrangements in the United States under California's established legal framework.
• November 2024: Nova IVF Fertility accelerated its clinic expansion roadmap targeting Tier 2 cities across India, responding to growing fertility awareness and rising demand in urban centers previously underserved by specialized assisted reproductive technology providers.
• September 2024: Ovation Fertility deepened its partnership with Genomic Prediction to expand access to advanced pre-implantation genetic testing within its surrogacy programs, improving embryo selection accuracy and live birth outcomes for intended parents across its clinic network.
• June 2024: IVIRMA Global announced expanded surrogacy support services across its European clinic locations, incorporating dedicated legal and psychological counseling pathways for intended parents navigating cross-border surrogacy arrangements and varying national regulatory environments.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.